ArticleClinical pharmacokinetics2026

Effect of Rivoceranib 200 mg Once Daily on the Pharmacokinetics of a Cocktail Probe Substrate of Cytochrome P450 Enzymes: A Phase I Trial in Healthy Volunteers.

David Nguyen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.